Phospholamban R14del disease: The past, the present and the future

E Vafiadaki, PC Glijnis, PA Doevendans… - Frontiers in …, 2023 - frontiersin.org
Arrhythmogenic cardiomyopathy affects significant number of patients worldwide and is
characterized by life-threatening ventricular arrhythmias and sudden cardiac death …

Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact

J Dave, N Raad, N Mittal, L Zhang… - Cardiovascular …, 2022 - academic.oup.com
Aims A mutation in the phospholamban (PLN) gene, leading to deletion of Arg14 (R14del),
has been associated with malignant arrhythmias and ventricular dilation. Identifying pre …

Myofilament alterations associated with human R14del-phospholamban cardiomyopathy

M Kumar, K Haghighi, S Koch, J Rubinstein… - International Journal of …, 2023 - mdpi.com
Phospholamban (PLN) is a major regulator of cardiac contractility, and human mutations in
this gene give rise to inherited cardiomyopathies. The deletion of Arginine 14 is the most …

[HTML][HTML] Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation

NM Stege, RA de Boer, CA Makarewich… - JACC: Basic to …, 2024 - Elsevier
The phospholamban (PLN) pathogenic gene variant, p. Arg14del (PLN-R14del), can lead to
dilated and arrhythmogenic cardiomyopathy, resulting in heart failure. PLN-R14del …

Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca2+ Handling and Arrhythmogenesis

E Vafiadaki, K Haghighi, DA Arvanitis… - International Journal of …, 2022 - mdpi.com
Phospholamban (PLN), a key modulator of Ca2+-homeostasis, inhibits sarcoplasmic
reticulum (SR) calcium-ATPase (SERCA2a) and regulates cardiac contractility. The human …

Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts

ME Rogalska, E Vafiadaki, Z Erpapazoglou… - Metabolism, 2023 - Elsevier
Arrhythmogenic cardiomyopathy (ACM) is characterized by life-threatening ventricular
arrhythmias and sudden cardiac death and affects hundreds of thousands of patients …

Evolving cardiovascular genetic counseling needs in the era of precision medicine

A Morales, J Goehringer, D Sanoudou - Frontiers in Cardiovascular …, 2023 - frontiersin.org
In the era of Precision Medicine the approach to disease diagnosis, treatment, and
prevention is being transformed across medical specialties, including Cardiology, and …

Unbiased complexome profiling and global proteomics analysis reveals mitochondrial impairment and potential changes at the intercalated disk in presymptomatic …

B Foo, H Amedei, S Kaur, S Jaawan, A Boshnakovska… - Plos one, 2024 - journals.plos.org
Phospholamban (PLN) is a sarco-endoplasmic reticulum (SER) membrane protein that
regulates cardiac contraction/relaxation by reversibly inhibiting the SERCA2a Ca2+ …

Early consequences of the phospholamban mutation PLN‐R14del+/− in a transgenic mouse model

C Maniezzi, M Eskandr, C Florindi, M Ferrandi… - Acta …, 2024 - Wiley Online Library
Aims The heterozygous phospholamban (PLN) mutation R14del (PLN R14del+/−) is
associated with a severe arrhythmogenic cardiomyopathy (ACM) developing in the …

[HTML][HTML] Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium

SR Cleary, ACT Teng, AD Kongmeneck, X Fang… - Journal of Biological …, 2025 - Elsevier
The sarco (endo) plasmic reticulum Ca 2+ ATPase (SERCA) is a membrane transporter that
creates and maintains intracellular Ca 2+ stores. In the heart, SERCA is regulated by an …